← Product Code [IYN](/productcode/IYN) · K254027 # Digital Color Doppler Ultrasound System (Marvo 95/Marvo 95 Elite/Marvo 90/Marvo 90 CV/Marvo 90 Pro/Marvo 90 Exp/Marvo 90 Elite/Marvo Expert/Marvo 85/Marvo 85 Pro/Marvo 85 Exp/Marvo 85 Elite/Marvo Senior/Marvo 75 Elite/Marvo 75i/Fenix 95/Fenix 95 Elite/Fenix 90/Fenix 90 Elite/Fenix Expert/Fenix 85/Fenix 85 Elite/Fenix Senior/Fenix 75 Elite/Fenix 75i/Endo 80/Endo 90) (K254027) _Sonoscape Medical Corp. · IYN · Aug 24, 2026 · Radiology · SESE_ **Canonical URL:** https://fda.innolitics.com/device/K254027 ## Device Facts - **Applicant:** Sonoscape Medical Corp. - **Product Code:** [IYN](/productcode/IYN.md) - **Decision Date:** Aug 24, 2026 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 892.1550 - **Device Class:** Class 2 - **Review Panel:** Radiology - **Attributes:** Pediatric ## Indications for Use The Marvo Senior Series Digital Color Doppler Ultrasound System is a general-purpose ultrasonic imaging system intended for use by qualified and appropriately trained healthcare professionals for ultrasound imaging, measurement, and analysis of the human body, which is intended to be used in a hospital or medical clinic. The system is intended for use in the following clinical applications: Fetal, Abdominal, Pediatric, Small Organ (breast, testes, thyroid), Cephalic (neonatal and adult), Trans-rectal, Trans-vaginal, Peripheral Vascular, Cerebral Vascular, Musculo-skeletal (Conventional and Superficial), Cardiac (pediatric and adult), OB/Gyn and Urology. Modes of operation include: B, M, PW Doppler, CW Doppler, Color Doppler, Color M Doppler, Power Doppler, Directional Power Doppler, Tissue Harmonic Imaging, Tissue Doppler Imaging, 3D/4D Imaging mode, Strain Elastography, Shear Wave Elastography, Contrast imaging and Combined modes: B/M, B/PWD, B/THI, M/Color M, B/Color Doppler, B/Color Doppler/PWD, B/Power Doppler/PWD. ## Device Story Mobile, software-controlled, color diagnostic ultrasound system; utilizes wide array of probes (linear, convex, phased) to transmit ultrasonic energy into patient body; processes received echoes to generate real-time images of anatomic structures and fluid flow. Operated by trained healthcare professionals in hospitals/clinics; provides B-mode, M-mode, Doppler (PW/CW/Color/Power/Directional), Tissue Harmonic, Tissue Doppler, 3D/4D, Strain/Shear Wave Elastography, and Contrast imaging. Output displayed on integrated color LCD monitor; used for clinical diagnostic imaging, measurement, and analysis. Includes automated measurement features (S-ORADS) and super-resolution contrast-enhanced ultrasound (URI-CEUS). System aids clinicians in visualizing internal anatomy and hemodynamics to support diagnostic decision-making. ## Clinical Evidence No clinical study is included in this submission. Bench testing only. ## Technological Characteristics Mobile console with touch screen, keyboard, and color LCD monitor. Supports linear, convex, and phased array probes. Complies with AAMI/ANSI ES 60601-1, IEC 60601-1-2, IEC 60601-2-37, ISO 10993-1, and AIUM/NEMA UD 2. Software-controlled system with multiple imaging modes including B, M, Doppler, Elastography, and Contrast imaging. Connectivity via integrated system architecture. ## Regulatory Identification An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories. ## Predicate Devices - S90 Exp Series Digital Color Doppler Ultrasound System ([K222596](/device/K222596.md)) ## Reference Devices - P60 Series Digital Color Doppler Ultrasound System ([K241949](/device/K241949.md)) - X11 Exp Series Digital Color Doppler Ultrasound System ([K252498](/device/K252498.md)) - P50 Series Digital Color Doppler Ultrasound System ([K170999](/device/K170999.md)) - Resona A10S Diagnostic Ultrasound System ([K242231](/device/K242231.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} FDA U.S. FOOD & DRUG ADMINISTRATION Sonoscape Medical Corp. Toki Wu Regulatory Affairs Director Rm. 201 & 202, 12th Bldg. Shenzhen Software Park Phase II, 1 Keji Middle 2nd Rd. Yuehai Subdistrict, Nanshan District Shenzhen, Guangdong 518057 CHINA August 24, 2026 Re: K254027 Trade/Device Name: Digital Color Doppler Ultrasound System (Marvo 95/Marvo 95 Elite/Marvo 90/Marvo 90 CV/Marvo 90 Pro/Marvo 90 Exp/Marvo 90 Elite/Marvo Expert/Marvo 85/Marvo 85 Pro/Marvo 85 Exp/Marvo 85 Elite/Marvo Senior/Marvo 75 Elite/Marvo 75i/Fenix 95/Fenix 95 Elite/Fenix 90/Fenix 90 Elite/Fenix Expert/Fenix 85/Fenix 85 Elite/Fenix Senior/Fenix 75 Elite/Fenix 75i/Endo 80/Endo 90) Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic Pulsed Doppler Imaging System Regulatory Class: Class II Product Code: IYN, IYO, ITX Dated: July 24, 2026 Received: July 24, 2026 Dear Toki Wu: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of U.S. Food & Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 www.fda.gov {1} K254027 - Toki Wu Page 2 Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn {2} K254027 - Toki Wu Page 3 (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Digitally signed by Michael D. O'hara -S Date: 2026.08.24 16:40:56 -04'00' For Yanna Kang, Ph.D. Assistant Director Mammography and Ultrasound Team DHT8C: Division of Radiological Imaging and Radiation Therapy Devices OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {3} | Indications for Use | | | | --- | --- | --- | | Please type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. | K254027 | ? | | Please provide the device trade name(s). | | ? | | Digital Color Doppler Ultrasound System (Marvo 95/Marvo 95 Elite/Marvo 90/Marvo 90 CV/Marvo 90 Pro/Marvo 90 Exp/Marvo 90 Elite/Marvo Expert/Marvo 85/Marvo 85 Pro/Marvo 85 Exp/Marvo 85 Elite/Marvo Senior/Marvo 75 Elite/Marvo 75i/Fenix 95/Fenix 95 Elite/Fenix 90/Fenix 90 Elite/Fenix Expert/Fenix 85/Fenix 85 Elite/Fenix Senior/Fenix 75 Elite/Fenix 75i/Endo 80/Endo 90) | | | | Please provide your Indications for Use below. | | ? | | The Marvo Senior Series Digital Color Doppler Ultrasound System is a general-purpose ultrasonic imaging system intended for use by qualified and appropriately trained healthcare professionals for ultrasound imaging, measurement, and analysis of the human body, which is intended to be used in a hospital or medical clinic. The system is intended for use in the following clinical applications: Fetal, Abdominal, Pediatric, Small Organ (breast, testes, thyroid), Cephalic (neonatal and adult), Trans-rectal, Trans-vaginal, Peripheral Vascular, Cerebral Vascular, Musculo-skeletal (Conventional and Superficial), Cardiac (pediatric and adult), OB/Gyn and Urology. Modes of operation include: B, M, PW Doppler, CW Doppler, Color Doppler, Color M Doppler, Power Doppler, Directional Power Doppler, Tissue Harmonic Imaging, Tissue Doppler Imaging, 3D/4D Imaging mode, Strain Elastography, Shear Wave Elastography, Contrast imaging and Combined modes: B/M, B/PWD, B/THI, M/Color M, B/Color Doppler, B/Color Doppler/PWD, B/Power Doppler/PWD. | | | | Please select the types of uses (select one or both, as applicable). | ☑ Prescription Use (21 CFR 801 Subpart D) ☐ Over-The-Counter Use (21 CFR 801 Subpart C) | ? | {4} 510(k) Summary ## 510(k) Summary This 510(k) Summary is being submitted in accordance with requirements of Title 21, CFR Section 807.92. The assigned 510(k) Number: K254027 1. Date of Preparation: July 24, 2026 2. Sponsor Identification **SONOSCAPE MEDICAL CORP.** Room 201 & 202, 12th Building, Shenzhen Software Park Phase II, 1 Keji Middle 2nd Road, Yuehai Subdistrict, Nanshan District, Shenzhen, 518057, Guangdong, China. Establishment Registration Number: 3004705634 Contact Person: Toki Wu Position: Regulatory Affairs Director Tel: +86-755-26722890 Fax: +86-755-26722850 Email: ra@sonoscape.net 3. Identification of Subject Device Common Name: Diagnostic Ultrasound System and Transducers Trade Name: Digital Color Doppler Ultrasound System (Marvo 95/Marvo 95 Elite/Marvo 90/Marvo 90 CV/Marvo 90 Pro/Marvo 90 Exp/Marvo 90 Elite/Marvo Expert/Marvo 85/Marvo 85 Pro/Marvo 85 Exp/Marvo 85 Elite/Marvo Senior/Marvo 75 Elite/Marvo 75i/Fenix 95/Fenix 95 Elite/Fenix 90/Fenix 90 Elite/Fenix Expert/Fenix 85/Fenix 85 Elite/Fenix Senior/Fenix 75 Elite/Fenix 75i/Endo 80/Endo 90) Regulatory Information | | CFR Number | Product Code | | --- | --- | --- | | Ultrasonic Pulsed Doppler Imaging System (Primary) | 892.1550 | 90-IYN | | Ultrasonic Pulsed Echo Imaging System | 892.1560 | 90-IYO | | Diagnostic Ultrasound Transducer | 892.1570 | 90-ITX | Classification Panel: Radiology 1 / 4 {5} 510(k) Summary--- Device Classification: II # Indication for Use: The Marvo Senior Series Digital Color Doppler Ultrasound System is a general-purpose ultrasonic imaging system intended for use by qualified and appropriately trained healthcare professionals for ultrasound imaging, measurement, and analysis of the human body, which is intended to be used in a hospital or medical clinic. The system is intended for use in the following clinical applications: Fetal, Abdominal, Pediatric, Small Organ (breast, testes, thyroid), Cephalic (neonatal and adult), Trans-rectal, Trans-vaginal, Peripheral Vascular, Cerebral Vascular, Musculo-skeletal (Conventional and Superficial), Cardiac (pediatric and adult), OB/Gyn and Urology. Modes of operation include: B, M, PW Doppler, CW Doppler, Color Doppler, Color M Doppler, Power Doppler, Directional Power Doppler, Tissue Harmonic Imaging, Tissue Doppler Imaging, 3D/4D Imaging mode, Strain Elastography, Shear Wave Elastography, Contrast imaging and Combined modes: B/M, B/PWD, B/THI, M/Color M, B/Color Doppler, B/Color Doppler/PWD, B/Power Doppler/PWD. # Device Description: This Marvo 95/Marvo 95 Elite/Marvo 90/Marvo 90 CV/Marvo 90 Pro/Marvo 90 Exp/Marvo 90 Elite/Marvo Expert/Marvo 85/Marvo 85 Pro/Marvo 85 Exp/Marvo 85 Elite/Marvo Senior/Marvo 75 Elite/Marvo 75i/Fenix 95/Fenix 95 Elite/Fenix 90/Fenix 90 Elite/Fenix Expert/Fenix 85/Fenix 85 Elite/Fenix Senior/Fenix 75 Elite/Fenix 75i/Endo 80/Endo 90 Digital Color Doppler Ultrasound System (hereafter as “Marvo Senior Series Digital Color Doppler Ultrasound System”) is an integrated preprogrammed color ultrasound imaging system, capable of producing high detail resolution intended for clinical diagnostic imaging applications. The basic principle is that system transmits ultrasonic energy into patient body and implements post processing of received echoes to generate onscreen display of anatomic structures and fluid flow within the body. This system is a Track 3 device that employs a wide array of probes that include linear array, convex array, phased array and etc. This system consists of a mobile console with touch screen and keyboard control panel, power supply module, color LCD monitor and optional probes. This system is a mobile, general purpose, software controlled, color diagnostic ultrasound system. Its basic function is to acquire ultrasound data and to display the image in B-Mode (including Tissue Harmonic Image), M-Mode, TDI, Color-Flow Doppler, Pulsed Wave Doppler, Continued Wave Doppler, Power Doppler and Directional Power Doppler Imaging, or the combination of these modes, Contrast Imaging, Strain Elastography, Shear Wave Elastography, SonoFusion, 3D/4D. 2 / 4 {6} 510(k) Summary # 4. Identification of Predicate Device | Type | Device | 510 (k) Number | Manufacturer | | --- | --- | --- | --- | | 1 Primary Predicate Device | S90 Exp Series Digital Color Doppler Ultrasound System | K222596 | SonoScape Medical Corp. | | 2 Reference Device | P60 Series Digital Color Doppler Ultrasound System | K241949 | SonoScape Medical Corp. | | 3 Reference Device | X11 Exp Series Digital Color Doppler Ultrasound System | K252498 | SonoScape Medical Corp. | | 4 Reference Device | P50 Series Digital Color Doppler Ultrasound System | K170999 | SonoScape Medical Corp. | | 5 Reference Device | Resona A10S Diagnostic Ultrasound System | K242231 | Mindray | # 5. Non-Clinical Test Conclusion Non-clinical tests were conducted to evaluate for acoustic output, biocompatibility, reprocessing effectiveness as well as electrical, mechanical, thermal and electromagnetic compatibility safety, and has been found to comply with the applicable medical device safety standards. The Marvo Senior Series Digital Color Doppler Ultrasound System has been designed and manufactured to meet the following standards. AAMI/ANSI ES 60601-1, Medical Electrical Equipment- Part 1: General requirements for basic safety and essential performance [Edition 3.2, 2021]; IEC 60601-1-2, Medical electrical equipment - Part 1-2 General requirements for basic safety and essential performance - Collateral standard: Electromagnetic disturbances - Requirements and tests [Edition 4.1, 2020]; IEC 60601-2-37, Medical Electrical Equipment - Part 2-37: Particular requirements for basic safety and essential performance of ultrasonic medical diagnostic and monitoring equipment [Edition 3.0, 2024]; ISO 10993-1, Biological Evaluation of Medical Devices, Part 1: evaluation and testing within a risk management process [2018]; AIUM/NEMA UD 2, Acoustic output measurement standard for diagnostic ultrasound equipment [Revision 3, 2009]. # 6. Clinical Test Conclusion No clinical study is included in this submission. # 7. Comparison with Predicate Devices 3 / 4 {7} 510(k) Summary The subject device Marvo Senior Series Digital Color Doppler Ultrasound System is comparable with and substantially equivalent to the predicate devices with regards to intended uses, imaging modes, acoustic output levels, probes and biopsy brackets supported, technical characteristics and features. - The Marvo Senior Series Digital Color Doppler Ultrasound System has the same intended use and imaging modes as the predicate device S90 Exp Series (K222596); - The Marvo Senior Series Digital Color Doppler Ultrasound System is designed in compliance with the FDA recognized electrical and physical safety standards, which are the same as the predicate device S90 Exp Series (K222596); - The acoustic output levels of the Marvo Senior Series Digital Color Doppler Ultrasound System are below the limits of FDA, which are the same as the predicate device S90 Exp Series (K222596); - The probes supported in the Marvo Senior Series Digital Color Doppler Ultrasound System have been mostly migrated from the predicate device S90 Exp Series (K222596) and P60 Series (K241949); the new probes L3-18U, xL3-18U, L3-18iU, L3-18AU, C1-7U, C1-7-MU, xC1-7U, xC1-7-MU, VC2-10U, P4-12U, S1-6U, xS1-6U, VE3-12U, EC3-12U and ER4-13U are equivalent to the probes cleared with predicate device SonoScape S90 Exp Series (K222596), P60 Series (K241949), X11 Exp Series (K252498) and P50 Series (K170999); - The biopsy brackets supported in the Marvo Senior Series Digital Color Doppler Ultrasound System have been mostly migrated from the predicate device S90 Exp Series (K222596) and P60 Series (K241949); the new biopsy brackets NGBL3-18, NGBxL3-18, NGBxC1-7, NGBC1-7, NGBS1-6, NGBxS1-6 and NGBEC3-12, they are equivalent to the biopsy brackets cleared with predicate device S90 Exp Series (K222596), P60 Series (K241949) and X11 Exp Series (K252498); - The Marvo Senior Series Digital Color Doppler Ultrasound System has one new feature (auto measurements) S-ORADS, which is equivalent to the corresponding manual measurement cleared in the predicate device S90 Exp Series (K222596); - The Marvo Senior Series Digital Color Doppler Ultrasound System add one new feature, URI-CEUS, which is equivalent to the Super Resolution CEUS function cleared with reference device Resona A10S (K242231). # 8. Conclusion The conclusions drawn from the nonclinical tests demonstrate that the subject device is as safe, as effective, and performs as well as the legally marketed predicate devices. 4 / 4 --- **Source:** [https://fda.innolitics.com/device/K254027](https://fda.innolitics.com/device/K254027) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com